| Literature DB >> 33207573 |
Joseph C Tsai1,2, Grant Casteneda1,2, Abby Lee1,2, Kypros Dereschuk1,2, Wei Tse Li1,2, Jaideep Chakladar1,2, Alecio F Lombardi2,3, Weg M Ongkeko1,2, Eric Y Chang2,3.
Abstract
Osteoarthritis (OA) is the most common joint disorder in the United States, and the gut microbiome has recently emerged as a potential etiologic factor in OA development. Recent studies have shown that a microbiome is present at joint synovia. Therefore, we aimed to characterize the intra-articular microbiome within osteoarthritic synovia and to illustrate its role in OA disease progression. RNA-sequencing data from OA patient synovial tissue was aligned to a library of microbial reference genomes to identify microbial reads indicative of microbial abundance. Microbial abundance data of OA and normal samples was compared to identify differentially abundant microbes. We computationally explored the correlation of differentially abundant microbes to immunological gene signatures, immune signaling pathways, and immune cell infiltration. We found that microbes correlated to OA are related to dysregulation of two main functional pathways: increased inflammation-induced extracellular matrix remodeling and decreased cell signaling pathways crucial for joint and immune function. We also confirmed that the differentially abundant and biologically relevant microbes we had identified were not contaminants. Collectively, our findings contribute to the understanding of the human microbiome, well-known OA risk factors, and the role microbes play in OA pathogenesis. In conclusion, we present previously undiscovered microbes implicated in the OA disease progression that may be useful for future treatment purposes.Entities:
Keywords: bacteria; inflammation; knee; microbiome; osteoarthritis; synovium
Mesh:
Year: 2020 PMID: 33207573 PMCID: PMC7697780 DOI: 10.3390/ijms21228618
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Summary of differential presence analysis. (A) Heatmap visualizing the differentially present microbes in OA vs. normal samples. (B) Phylogeny tree of differentially present microbes with red bars representing the number of OA patients with a microbial presence for each microbe.
Figure 2Pathways and genes associated with GSEA-correlated microbes. (A) Balloon plot illustrating the microbes and the strength of their association to gene clusters using weighted correlation network analysis (WGCNA). The significance of the correlation is represented by the size of the balloon, where the larger the balloon, the more significant the correlation. (B) Heatmap showing the top pathways of each cluster of genes found using Reactome Fi. (C) Boxplots presenting the association for the most significant IA genes involved within the top pathways.
Figure 3(A) Gene set enrichment analysis (GSEA) correlations of significantly upregulated microbes including multiple Pseudomonas, Unidentified Eubacterium Clone ESH20b-4, Obligately Oligotrophic Bacterium POCPN-83, Uncultured Bacterium (77133), and Cupriavidus Necator with canonical pathways and immunologic signatures (nominal p < 0.05). (B) Select GSEA plots of immunogenic signatures for the top three most significant microbes. A peak on the left side of the plot indicates that higher abundance of the microbe correlates with higher expression of the genes in the gene set whereas a valley on the right side of the plot indicates that lower abundance of the microbe correlates to lower expression of the genes in the gene set.
Figure 4(A) Relative expression of different immune cell types amongst OA patients. (B) Boxplots presenting the association between abundance of 9 GSEA-correlated microbes and different immune cell types.
Figure 5Contamination correction screening using Spearman’s correlation for GSEA-correlated microbes. All microbes with a positive slope of total microbial read count vs. read count of the specific microbe are shown here. (A) Differentially abundant microbes from comparing OA samples vs. normal samples (Kruskal–Wallis Test, p < 0.05). (B) Scatter plots of normal samples. (C) Scatter plots of OA samples.
Figure 6Schematic of analysis and workflow.